A股異動丨迅遊科技(300467.SZ)跌停 實控人減持1.4%股份
格隆匯12月30日丨迅遊科技(300467.SZ)今日大幅低開下跌,盤中幾次跌停再次打開。現大跌9.95%,報19.45元,暫成交3.39億元,最新總市值43.44億元。

迅遊科技(300467.SZ)日前公告,3名控股股東、實控人已合計減持312.83萬股,減持比例合計達到1.4%。
值得一提的是,12月23日實控人終止轉讓5%股權給高投集團,股價在12月18日至12月20日期間,曾經連續收出3個漲停板。高投集團擬受讓迅遊科技5%股分,主要是為支持民營企業紓困,推動化解公司控股股東、實際控制人股權質押平倉風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.